Medtech stories we missed this week: Dec. 22, 2017

From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its

These artificial heart muscle patches can repair dead heart muscles

A team of biomedical engineers have developed a fully functioning artificial human heart muscle that can be used as a patch to repair dead heart muscle. Duke University biomedical engineers developed the patch to be used in human patients who have previously suffered a heart attack. “Right now, virtually all existing therapies are aimed at

Medtech stories we missed this week: Dec. 8, 2017

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press releasethat it has signed its first European distribution deal with Italian company Moss and

PEEK formulations for new implantable devices

Since the late 1990s, polyether ether ketone has become a go-to material for companies that manufacture orthopedic implants, thanks to its radiolucency and anatomical properties. Now, custom formulations of PEEK are enabling new potential applications for the polymer. Lawrence Acquarulo, Foster Corp. Polymers have always played a role in modern implantable medical devices. But until

Medtech stories we missed this week: Oct. 27, 2017

From RadiaDyne’s FDA expansion to NuVasive launching its new implants, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA expands indications for RadiaDyne’s OARtrac dose monitor RadiaDyne announced in an Oct. 24 press release that it has received additional FDA clearance for its upcoming OARtrac. The OARtrac allows

The top 10 medical disruptors of 2018

Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor is that it has to be so innovative that it could change healthcare in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from

Pages: 1 2 3 4 5 6 7 8 9 10 11

Medtech stories we missed this week: Oct. 20, 2017

From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime

The 11 most innovative medical devices of 2017

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Spinal cord stimulator could curb opioid prescriptions: Here’s how

The first implantation of Nuvectra’s Algovita Spinal Cord Stimulation System was recently performed in Northern California. The FDA-approved Algovita SCS System was able to successfully treat a injured veteran’s chronic pain to reduce the use of opioids to battle the pain. “Following injuries sustained in the line of duty, this particular patient had multiple surgeries

Blood metal ion levels help determine low-risk ARMD patients

A new study suggests that blood metal ion levels can determine patients who have a low risk of having adverse reactions to metal debris (ARMD). Patients who receive metal-on-metal artificial hips tend to be at risk of having complications due to ARMD. However, researchers discovered that blood metal ion levels that are specific to the

Medtech stories we missed this week: Aug. 18, 2017

From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for

Magnetic fields can destroy biofilms on implants: Here’s how

Alternating magnetic fields may be the key to fighting bacteria that grows on artificial joints, according to new research from the University of Texas Southwestern. Researchers at UT Southwestern claim that short exposure to high-frequency alternating magnetic fields (AMF) has the potential to destroy bacteria that ends up in biofilms growing on the surface of

This 3D printed implant replaces skull bone

A New Jersey doctor turned to Johnson & Johnson’s DePuy Synthes and a 3D printed implant to replace missing skull bone in a patient. The procedure was performed after the patient suffered brain swelling and the skull became infected. Dr. Gaurav Gupta, assistant professor of neurosurgery at Rutgers Robert Wood Johnson Medical School, had to

Could crystal-based electronics enable medtech innovation?

New crystal-based electronics – in which a laser etches electronic circuitry into a crystal – could enable better electrical interfaces between implantable medical devices and biological tissue, according to the lead researcher behind the technology. “Electrical conductivity affects how cells adhere to a substrate. By optically defining highly conductive regions on the crystal, cells could

9 battery and power source advances you need to know

In the drive toward tinier implantable medical devices and wearable health sensors, battery and power source technology has been a major stumbling block. As experts noted in a discussion about battery technology during DeviceTalks Minnesota in June, battery innovation in the field is especially slow. Going too fast has its risks, too. Case in point

Pages: 1 2 3 4 5 6 7 8 9 10